Related Experiment Video
Updated: Jun 2, 2025

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion
Published on: May 26, 2022
Approaches and Challenges in Managing Treatment-Resistant Hypertension: A Case Report
Julian Morano1, Samer Kholoki2
1Internal Medicine, Saint James School of Medicine, The Valley, AIA.
Abstract:
Treatment-resistant hypertension (TRH) is defined by consistently elevated blood pressure readings unresponsive to medical management. In clinical practice, it poses a significant challenge due to the intertwining variables that may cause the issue to persist such as lifestyle, genetics, and other comorbidities, as opposed to simple medication non-adherence. This report describes the case of a 68-year-old female patient presenting for a routine follow-up with persistently elevated ambulatory blood pressure readings. The patient was compliant with her medication regimen and followed lifestyle modification guidelines. Physical exam and review of systems showed no changes relative to previous visits. Laboratory findings were insignificant other than a low estimated glomerular filtration rate (eGFr) of 52. The patient's condition was stable but required further management to bring blood pressure readings into or closer to optimal range. This case looks at how the patient was managed and the rationale behind these decisions based on the patient's clinical history. It also emphasizes the importance of regular monitoring and constant adjustment of medical management to treatment for patients with TRH due to its unrelenting nature.
More Related Videos
Related Concept Videos
Hypertension and Regulation of Blood Pressure
Drug Therapy
Antianxiety Medications
Errors occurring during blood pressure monitoring
Several factors...
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Psychosis: Goals of Pharmacotherapy

